Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties
M Boztas, Y Cetinkaya, M Topal, I Gulcin… - Journal of medicinal …, 2015 - ACS Publications
Journal of medicinal chemistry, 2015•ACS Publications
Cyclopropylcarboxylic acids and esters and cyclopropylmethanols incorporating
bromophenol moieties were investigated as inhibitors of the carbonic anhydrase enzyme
(CA; EC 4.2. 1.1). The cis-and trans-esters 5 and 6 were obtained from the reaction of 4-allyl-
1, 2-dimethoxybenzene (4) with ethyl diazoacetate, which after bromination with Br2 gave
two isomeric monobromides (11 and 15), four isomeric dibromides (12, 13, 16, and 17), and
two isomeric tribromides (14 and 18). The carboxylic acids 7, 8, and 19–26 were thereafter …
bromophenol moieties were investigated as inhibitors of the carbonic anhydrase enzyme
(CA; EC 4.2. 1.1). The cis-and trans-esters 5 and 6 were obtained from the reaction of 4-allyl-
1, 2-dimethoxybenzene (4) with ethyl diazoacetate, which after bromination with Br2 gave
two isomeric monobromides (11 and 15), four isomeric dibromides (12, 13, 16, and 17), and
two isomeric tribromides (14 and 18). The carboxylic acids 7, 8, and 19–26 were thereafter …
Cyclopropylcarboxylic acids and esters and cyclopropylmethanols incorporating bromophenol moieties were investigated as inhibitors of the carbonic anhydrase enzyme (CA; EC 4.2.1.1). The cis- and trans-esters 5 and 6 were obtained from the reaction of 4-allyl-1,2-dimethoxybenzene (4) with ethyl diazoacetate, which after bromination with Br2 gave two isomeric monobromides (11 and 15), four isomeric dibromides (12, 13, 16, and 17), and two isomeric tribromides (14 and 18). The carboxylic acids 7, 8, and 19–26 were thereafter obtained by hydrolysis of the synthesized esters. All these bromophenol derivatives were tested against human (h) CA isoenzymes I and II (cytosolic, ubiquitous isoforms) and hCA IX and XII (transmembrane, tumor-associated enzymes). All tested bromophenols exhibited excellent inhibitory effects, in the low nanomolar range, with Ki values in the range of 0.54–59 nM against hCA I and in the range of 0.97–12.14 nM against hCA II, whereas they were low micromolar inhibitors against hCA IX and XII. The best hCA I inhibition was observed in new bromophenol derivative 20 (Ki = 0.54 nM). On the other hand, new bromophenol derivative 12 showed a powerful inhibition effect against hCA II (Ki = 0.97 nM).
ACS Publications